Articles related to PRECISION MEDICINE

In the rapidly evolving field of oncology, artificial intelligence (AI) stands out not just for its potential to revolutionize cancer care, but also for the complex ethical and practical challenges it presents. A recent survey highlights both the enthusiasm and caution among oncologists regarding AI’s integration into clinical practice.

UT Southwestern’s pioneering use of SCINTIX biology-guided radiotherapy represents a major advancement in precision oncology, targeting bone and lung cancers with a novel approach that combines PET imaging and radiotherapy for more effective treatment.

AI’s transformative role in breast cancer care goes beyond prediction—it offers a nuanced evaluation of both cancerous and non-cancerous elements, guiding individualized treatment plans. Learn how this innovation minimizes unnecessary chemotherapy, prioritizes patient outcomes, and heralds a new era in precision medicine.

As we navigate this new era of oncology care, it’s important to remember that only 38% of studies combining chemotherapy with a targeted treatment administered both drugs at full dose. This underscores the need for careful dose adjustments when combining different classes of drugs.

Discover how MatchMiner is transforming the landscape of precision medicine by efficiently connecting patients with suitable clinical trials, thereby accelerating the adoption of personalized therapies.

Learn about a ground-breaking strategy for treating uncommon brain tumors like papillary craniopharyngiomas (PCPs), where precision medicine and BRAF/MEK inhibitors marked a major improvement in brain cancer treatment by drastically reducing tumor size.